| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/09/2006 | US20060051341 Administering about 1 unit to about 3,000 units of a native botulinum toxin subcutaneously, intramuscularly, subdermally, intradermally or transdermally to a buttock of a patient having a buttock deformity |
| 03/09/2006 | US20060051340 Hemostatic materials |
| 03/09/2006 | US20060051339 Composition for treatment of oily skin and acne prevention and methods of making and using same |
| 03/09/2006 | US20060051338 Inhibition of mitogen-activated protein kinases in cardiovascular disease |
| 03/09/2006 | US20060051337 Prevent the growth of fungi, yeast, bacteria, and cyanobacteria on various surfaces, including, medical devices and instruments, toys, bathroom and kitchen surfaces, floors, and the underside of ships |
| 03/09/2006 | US20060051336 Bacteriolytic complex, method of its production, and strain for realization of the method |
| 03/09/2006 | US20060051335 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | US20060051322 Method for therapy of neurodegenerative disease of the brain |
| 03/09/2006 | US20060051320 Lyophilized formulations of pegylated interferon which are prepared using trehalose as a cryoprotectant; formulations have a low moisture content, which helps stabilize the pegylated interferon during storage at room temperature |
| 03/09/2006 | US20060051319 Neuroprotective effect of solubilized UDCA in focal ischemic model |
| 03/09/2006 | US20060051318 Medical composition for treating ischemic cardiac failure |
| 03/09/2006 | US20060051315 Polymers for delivering peptides and small molecules in vivo |
| 03/09/2006 | US20060051302 Methods of treating dermal/epidermal junctions and cosmetic preparations for use therein |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | DE102004043802A1 Mouth and dental care- and cleaning agent, useful for inflammatory diseases of the mouth and oral cavity e.g. gingivitis, comprises humectant and a protein of leguminous seeds e.g. protein of soy seeds |
| 03/09/2006 | DE102004041716A1 Verfahren zur Herstellung einer Ingwer-Fraktion und deren Verwendung zur Inhibierung humaner CYP Enzyme A process for the preparation of a ginger fraction and their use for the inhibition of human CYP enzymes |
| 03/09/2006 | DE10108412B4 Pigmentepithelzelle des Auges, ihre Herstellung und Verwendung in der Therapie einer Augen- oder Nervenerkrankung Pigment epithelial cell of the eye, their preparation and use in the therapy of a nervous disease or eye |
| 03/09/2006 | CA2580748A1 Methods for treating cancer |
| 03/09/2006 | CA2579093A1 Compositions and methods for modulating pgc-1.alpha. to treat neurological diseases and disorders |
| 03/09/2006 | CA2579012A1 Use of il-6 in vascular complications |
| 03/09/2006 | CA2578995A1 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |
| 03/09/2006 | CA2578904A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 03/09/2006 | CA2578252A1 Glp-1 and exendin related invention |
| 03/09/2006 | CA2578232A1 Methods to enhance hemodynamic stability using oxygen carrying compositions |
| 03/09/2006 | CA2578212A1 Methods for promoting wound healing |
| 03/09/2006 | CA2577812A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 03/09/2006 | CA2577451A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | CA2577017A1 Method and device for diagnosing and treating insulin-like growth factor deficiency disorders |
| 03/09/2006 | CA2570735A1 Treatment of hiv infection by t-cell modulation |
| 03/08/2006 | EP1632778A2 Natural ligand of gpcr chemr23 and uses thereof |
| 03/08/2006 | EP1632574A1 Fibroblast growth factor homologs |
| 03/08/2006 | EP1632561A1 Protein-containing granules and granule formulations |
| 03/08/2006 | EP1632501A1 Process for preparing a concentrate of von Willebrand factor with chromatography and concentrate of von Willebrand factor obtained according to said process |
| 03/08/2006 | EP1632500A2 A lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632249A1 Osteogenesis-promotion enhancer and method of screening the same |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/08/2006 | EP1632246A2 Medicament for local use |
| 03/08/2006 | EP1632245A1 ICA512 couples insulin secretion and gene expression in Beta-cells |
| 03/08/2006 | EP1632244A1 Preventives or remedies for hepatopathy |
| 03/08/2006 | EP1632242A2 Novel method for down-regulation of amyloid |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632238A1 Encapsulated cells adapted for implantation into the aqueous and vitreous humor of the eye |
| 03/08/2006 | EP1632231A2 Skin penetration enhancing components |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631683A1 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 |
| 03/08/2006 | EP1631676A2 Transducible dna-binding proteins |
| 03/08/2006 | EP1631670A2 Conserved hbv and hcv sequences useful for gene silencing |
| 03/08/2006 | EP1631669A2 Cochleate compositions directed against expression of proteins |
| 03/08/2006 | EP1631665A1 Novel phosphorylated sequences of the phosphatase cdc25b, antibodies for said sequences and use thereof |
| 03/08/2006 | EP1631592A2 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 03/08/2006 | EP1631588A2 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 03/08/2006 | EP1631586A2 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy |
| 03/08/2006 | EP1631554A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 03/08/2006 | EP1631375A2 Injectable hydrogel microspheres from aqueous two-phase system |
| 03/08/2006 | EP1631319A2 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/08/2006 | EP1631317A2 Use of vegf inhibitors for tumor regression |
| 03/08/2006 | EP1631313A2 Combination therapy for b cell disorders |
| 03/08/2006 | EP1631309A2 Protein kinase c peptides for use in withdrawal |
| 03/08/2006 | EP1631308A2 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 03/08/2006 | EP1631307A1 Methods to mobilize progenitor/stem cells |
| 03/08/2006 | EP1631306A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 03/08/2006 | EP1631305A2 Sincalide formulations |
| 03/08/2006 | EP1631303A2 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
| 03/08/2006 | EP1631299A2 Methods and compositions to treat myocardial conditions |
| 03/08/2006 | EP1631281A2 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 03/08/2006 | EP1631268A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 03/08/2006 | EP1631266A2 A method of treating degenerative disc disease |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1631243A2 Sexual hygienic composition |
| 03/08/2006 | EP1631237A2 Proteoglycan degrading mutants for treatment of cns |
| 03/08/2006 | EP1631234A2 Compositions and methods for the treatment of cns injuries |
| 03/08/2006 | EP1494703B1 Chemokines mutants having improved oral bioavailability |
| 03/08/2006 | EP1472290A4 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 03/08/2006 | EP1429689A4 Rational drug therapy device and methods |
| 03/08/2006 | EP1313763B1 Method for the extraction and the use of antibiotically effective peptides for treating infectious diseases |
| 03/08/2006 | EP1290013B1 Apo-ai/aii peptide derivatives |
| 03/08/2006 | EP1286658B1 Gamma-ifn liquid-droplet aerosol and method |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1265990B1 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 03/08/2006 | EP1257581B1 Compounds related to or derived from gfr alpha 4 and their use |
| 03/08/2006 | EP1244670B1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1218019B1 Oncolytic vesicular stomatitis virus |
| 03/08/2006 | EP1206261B1 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1179588B1 Human brain carboxypeptidase b |
| 03/08/2006 | EP1150704B1 Melagatran for the treatment of inflammation |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP1041995B1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1032662B1 Methods and compositions for immunomodulation |
| 03/08/2006 | EP1003774B1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 03/08/2006 | EP0983303B1 Method for the production of non-immunogenic proteins |
| 03/08/2006 | EP0946730B1 Mutants of streptococcal toxin c and methods of use |
| 03/08/2006 | EP0920502B1 Methods and means for modifying complement activation |
| 03/08/2006 | EP0910628B1 Inactivation resistant factor viii |
| 03/08/2006 | EP0870039B1 Recombinant fusion proteins to growth hormone and serum albumin |